Back to Agenda
The Value of Strategic Partnerships: From Nice to Have to Necessity
Session Chair(s)
Oana Borse, JD
Global Account Director
RWS Life Sciences, Germany
In most work situations, we wear multiple hats. You may be the client with a goal that often requires you to work with vendors. At other times, you may be the vendor, helping to deliver the goal. Sometimes, you may be both. This is often true when it comes to clinical research. Sponsors rely on CROs who in turn collaborate with third party vendors to successfully conduct clinical trials. So how does this sponsor-client-vendor relationship work? The key is trust. When you build a strong partnership with your vendors and clients, you have to feel confident that your partner will deliver, allowing you to focus on bringing drugs and therapies to market for the end customer, the patient. The same applies for patients. Trust and transparent communication is key to keeping patients engaged. especially in Decentralized Trials. In this session, we’ll discuss the shift from purely transactional to strategic collaborations and how a strong partnership leads to success for both the client and the vendor, including best practices that can make or break trust in the client-vendor relationship.
Speaker(s)
Lee-Ann Montano, MA
Parexel International, United States
Principal Consultant
Have an account?